Eli Lilly & Co. (LLY)
Healthcare – PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 50,000
- Market Cap
- $1.08T
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
SentiSense also tracks daily options readings for Eli Lilly & Co.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Eli Lilly & Co. stock analysis, sentiment tracking, and market intelligence on SentiSense.